Showing 8,881 - 8,900 results of 107,686 for search '(complement OR (implement OR implementing))', query time: 0.34s Refine Results
  1. 8881
  2. 8882

    Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. by Anders Krarup, Russell Wallis, Julia S Presanis, Péter Gál, Robert B Sim

    Published 2007-07-01
    “…The complement system is an important immune mechanism mediating both recognition and elimination of foreign bodies. …”
    Get full text
    Article
  3. 8883
  4. 8884

    Mixed Plant Viral Infections: Complementation, Interference and Their Effects, a Review by Monica R. Sánchez-Tovar, Rafael F. Rivera-Bustamante, Diana L. Saavedra-Trejo, Ramón Gerardo Guevara-González, Irineo Torres-Pacheco

    Published 2025-02-01
    “…During a mixed infection, the following types of interactions basically occur: complementation and interference, the effect of which produces synergism, antagonism, or no effect. …”
    Get full text
    Article
  5. 8885
  6. 8886

    The Relationship between Complements and Age-Related Macular Degeneration and Its Pathogenesis by Liyuan Chu, Chaoran Bi, Caiming Wang, Hongyan Zhou

    Published 2024-01-01
    “…Complement proteins are widely distributed in serum and tissue fluid. …”
    Get full text
    Article
  7. 8887
  8. 8888

    Cell-bound complement activation products associate with lupus severity in SLE by Richard A Furie, Daniel J Wallace, Judith A James, Susan Manzi, Amit Saxena, Rosalind Ramsey-Goldman, Chaim Putterman, John Conklin, Anca Askanase, Jill P Buyon, Elena Massarotti, Roberta Vezza Alexander, Sonali Narain, Cristina Arriens, Kenneth C Kalunian, Christopher E Collins, Ghalib A Bello, Joseph Ahearn

    Published 2020-10-01
    “…Objectives To evaluate the association between lupus severity and cell-bound complement activation products (CB-CAPs) or low complement proteins C3 and C4.Methods All subjects (n=495) fulfilled the American College of Rheumatology (ACR) classification criteria for SLE. …”
    Get full text
    Article
  9. 8889
  10. 8890
  11. 8891
  12. 8892
  13. 8893
  14. 8894
  15. 8895
  16. 8896
  17. 8897

    Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators by Julia J. Shi, Yusuf M. Ozcan, Carlos I. Ayala Santos, Hetalkumari Patel, Jamile Shammo, Taha Bat

    Published 2024-12-01
    “…Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder which is caused by mutations in phosphatidylinositol glycan class A leading to hemolysis of red blood cells via complement inhibition. The first treatment for PNH, eculizumab, was FDA approved in 2007. …”
    Get full text
    Article
  18. 8898

    A cytosolic glyoxylate shunt complements the canonical photorespiratory pathway in Arabidopsis by Xiaotong Jiang, Amanda M. Koenig, Berkley J. Walker, Jianping Hu

    Published 2025-04-01
    “…Our genetic, transcriptomic and metabolic profiling analyses together reveal a connection between cytosolic glyoxylate and a non-canonical photorespiratory route mediated by HPR2, which we name the photorespiratory glyoxylate shunt. This shunt complements the canonical photorespiratory pathway and is especially critical when high photorespiratory fluxes are required and when the major photorespiratory pathway is deficient. …”
    Get full text
    Article
  19. 8899
  20. 8900